1. Home
  2. PMCB vs CJJD Comparison

PMCB vs CJJD Comparison

Compare PMCB & CJJD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • CJJD
  • Stock Information
  • Founded
  • PMCB 1996
  • CJJD 2003
  • Country
  • PMCB United States
  • CJJD China
  • Employees
  • PMCB N/A
  • CJJD N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • CJJD Retail-Drug Stores and Proprietary Stores
  • Sector
  • PMCB Health Care
  • CJJD Consumer Staples
  • Exchange
  • PMCB Nasdaq
  • CJJD Nasdaq
  • Market Cap
  • PMCB 13.9M
  • CJJD 12.2M
  • IPO Year
  • PMCB N/A
  • CJJD N/A
  • Fundamental
  • Price
  • PMCB $1.64
  • CJJD $2.10
  • Analyst Decision
  • PMCB
  • CJJD
  • Analyst Count
  • PMCB 0
  • CJJD 0
  • Target Price
  • PMCB N/A
  • CJJD N/A
  • AVG Volume (30 Days)
  • PMCB 57.4K
  • CJJD 13.8K
  • Earning Date
  • PMCB 12-13-2024
  • CJJD 07-30-2024
  • Dividend Yield
  • PMCB N/A
  • CJJD N/A
  • EPS Growth
  • PMCB N/A
  • CJJD N/A
  • EPS
  • PMCB 0.54
  • CJJD N/A
  • Revenue
  • PMCB N/A
  • CJJD $154,541,077.00
  • Revenue This Year
  • PMCB N/A
  • CJJD N/A
  • Revenue Next Year
  • PMCB N/A
  • CJJD N/A
  • P/E Ratio
  • PMCB $3.06
  • CJJD N/A
  • Revenue Growth
  • PMCB N/A
  • CJJD 3.85
  • 52 Week Low
  • PMCB $1.39
  • CJJD $1.34
  • 52 Week High
  • PMCB $2.58
  • CJJD $5.00
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 40.27
  • CJJD 49.85
  • Support Level
  • PMCB $1.72
  • CJJD $2.08
  • Resistance Level
  • PMCB $1.94
  • CJJD $2.24
  • Average True Range (ATR)
  • PMCB 0.17
  • CJJD 0.20
  • MACD
  • PMCB -0.01
  • CJJD -0.03
  • Stochastic Oscillator
  • PMCB 9.27
  • CJJD 12.71

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About CJJD China Jo-Jo Drugstores Inc. (Cayman Islands)

China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.

Share on Social Networks: